News
Former LigoCyte Pharmaceuticals research facility in Bozeman set to close within two years
June 18, 2015 /
akeda Pharmaceutical Company announced earlier this month plans to close its vaccine facility in Bozeman as part of a company-wide consolidation over the next two years.
The Bozeman facility, formerly LigoCyte Pharmaceuticals at 2155 Analysis Drive, is home to labs, business offices and some manufacturing, according to Don Beeman, former CEO of LigoCyte.
By Daniel DeMay Chronicle Staff Writer
MATR Supporters (view all)
Posted in: Montana Business
Sorry, we couldn't find any posts. Please try a different search.